N-(2-(2,3-dihydroimidazo[2,1-b]thiazol-6-yl)ethyl)-5-imino-5H-thiazolo[3,2-a]pyrimidine-6-carboxamide

ID: ALA5290718

Max Phase: Preclinical

Molecular Formula: C14H14N6OS2

Molecular Weight: 346.44

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N=c1c(C(=O)NCCc2cn3c(n2)SCC3)cnc2sccn12

Standard InChI:  InChI=1S/C14H14N6OS2/c15-11-10(7-17-13-20(11)4-6-22-13)12(21)16-2-1-9-8-19-3-5-23-14(19)18-9/h4,6-8,15H,1-3,5H2,(H,16,21)

Standard InChI Key:  YTRALBVYDVDYCR-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 23 26  0  0  0  0  0  0  0  0999 V2000
    1.4579    1.2805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1725    1.6928    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8844    1.2809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8844    0.4557    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1743    0.0440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4579    0.4520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6886    1.5311    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.1594    0.8774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6674    0.2098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1743   -0.7812    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7433    0.0394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7433   -0.7856    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0287    0.4520    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6859    0.0394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4005    0.4520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1151    0.0394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1151   -0.7856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9193   -1.0358    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3901   -0.3821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8980    0.2853    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4136   -1.6928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1594   -1.4436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1505   -0.6341    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  2  0
  4  3  1  0
  5  4  1  0
  1  6  2  0
  6  5  1  0
  3  7  1  0
  7  8  1  0
  9  8  2  0
  4  9  1  0
  5 10  2  0
  6 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 17 16  2  0
 17 18  1  0
 18 19  1  0
 20 19  2  0
 16 20  1  0
 18 21  1  0
 21 22  1  0
 23 22  1  0
 19 23  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5290718

    ---

Associated Targets(Human)

CLEC4M Tbio C-type lectin domain family 4 member M (115 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 346.44Molecular Weight (Monoisotopic): 346.0671AlogP: 1.15#Rotatable Bonds: 4
Polar Surface Area: 88.07Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.59CX LogP: 1.08CX LogD: 1.08
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.74Np Likeness Score: -2.29

References

1. Sethi A, Sanam S, Alvala M..  (2021)  Non-carbohydrate strategies to inhibit lectin proteins with special emphasis on galectins.,  222  [PMID:34146913] [10.1016/j.ejmech.2021.113561]

Source